Improvement of quality of life indicators in patients with metabolic syndrome after correction of hemodynamically significant coronary stenoses and dyslipidemia

It is known that metabolic syndrome is currently the leading cause of the development of cardiovascular pathology, which occupies a leading position in the structure of mortality not only in the Russian population, but also in the world. The prevalence of MS is growing, which is associated with stressful professions, eating disorders. The presence of MS is associated with arterial hypertension and atherosclerosis of the arteries of any localization. In this regard, the purpose of our study was to study the quality of life in patients with MS, depending on the severity of coronary atherosclerosis. Materials and methods: The study included 239 patients (142 men, 97 women) with MS with atherosclerosis of the coronary and carotid arteries. The number of subjects in group 1 (n=141), of which 101 were men and 40 were women. The second group consisted of 84 male and 14 female patients (n=98). The control group consisted of 70 people (27 men, 43 women) with grade 1-3 hypertension. The age of the subjects was 31-56 years. All patients underwent: collection of complaints and anamnesis, assessment of body mass index (BMI); determination of the lipid spectrum, blood glucose, glycated hemoglobin. Microalbuminuria and glomerular filtration rate were determined. Instrumental studies were carried out: ultrasound examination of brachiocephalic vessels with determination of the thickness of the intima-media complex and the percentage of carotid artery stenosis; coronary angiography on the General Electric Innova 3100 angiographic complex. Based on the results of coronary angiography, the patients were divided into two subgroups: group 1 - with coronary artery stenosis of less than 50% (n=141), group 2 - with stenosis of 50% or more (n=98), group 3 (control) without stenotic lesions of the coronary arteries. A non-specific questionnaire “SF-36 Health Status Survey” was used to assess the quality of life. Results: assessing physical functioning and mental health, there was a significant decrease in these indicators in patients of group 2, in whom, according to coronary angiography, hemodynamically significant coronary artery stenoses were diagnosed, a strong correlation (r=0.730; p=0.005) was revealed between deterioration in quality of life and hemodynamically significant stenosis of the carotid and coronary arteries. Restriction of physical activity and reduction of daily activities were more significant in group 2 compared to groups 1 and 3. The feeling of uncertainty with restless expectation and fears, as well as a feeling of depression prevailed in men. However, patients after percutaneous coronary intervention, as well as with lipidogram correction, assessed the quality of life with some restriction of physical activity, but with significant social functioning. Conclusions: hemodynamically significant atherosclerosis of the carotid and coronary arteries is a predictor of deterioration in the quality of life, especially in men. The use of the international questionnaire “SF-36 Health Status Survey” is appropriate for assessing the health and vital activity in patients with MS and hypertension, with signs of atherosclerosis. The interaction of a cardiologist, an endocrinologist and a psychotherapist are justified for the most optimal management of patients with comorbid pathology.

arterial hypertension, atherosclerosis, quality of life, metabolic syndrome

1. Filimonov E. S., Korotenko O. Yu. Atherosclerotic artery lesion in miners with metabolic syndrome. Occupational medicine and industrial ecology. 2022;62(4):232-237. (in Russ.) doi: 10.31089/1026-9428-2022-62-4-232-237.@@ Филимонов Е. С., Коротенко О. Ю. Атеросклеротическое поражение артерий у шахтёров с метаболическим синдромом. Медицина труда и промышленная экология. 2022;62(4):232-237. doi: 10.31089/1026-9428-2022-62-4-232-237.

2. World Health Organization. Avalable at: https://www.who.int/ru/news/item/09-12-2020-who-reveals-leading-causes-of-death-and-disability-worldwide-2000-2019 Accessed at: 05.05.2023.

3. Wolf D., Ley K. Immunity and Inflammation in Atherosclerosis. Circ. Res. 2019;124(2):315-327. doi: 10.1161/CIRCRESAHA.118.313591.

4. Pogorelova O. A., Tripoten M. I., Guchaeva D. A., Shahnovich R. M., Ruda M. Y., Bala-khonova T. V. Carotid Plaque Instability in Patients with Acute Coronary Syndrome as Assessed by Ultrasound Duplex Scanning. Kardiologiia. 2017;57(12):5-15. (In Russ.) doi: 10.18087/cardio.2017.12.10061.@@ Погорелова О. А., Трипотень М. И., Гучаева Д. А., Шахнович Р. М., Руда М. Я., Балахонова Т. В. Признаки нестабильности атеросклеротической бляшки в сонных артериях у больных с острым коронарным синдромом по данным ультразвуового дуплексного сканирования. Кардиология. 2017; 57 (12): 5-15.

5. Dalen J. E., Alpert J. S., Goldberg R. J. et al. The epidemic of the 20(th) century: coronary heart disease. Am J Med. 2014 Sep;127(9):807-12. doi: 10.1016/j.amjmed.2014.04.015.

6. The World Health Organization. The top ten causes of death. Avalable at: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death Accessed 05.05.2023.

7. Enina T. N., Kuznetsov V. A., Salamova L. A. et al. Biomarkers of immune inflammation, fibrosis, neurohumoral activation and catecholamines in patients with devices for cardioversion-defibrillation and cardiac resynchronization therapy. Materials of the National Congress “Heart Failure, 2018”. Moscow; December 14-15, 2018:23 (In Russ.).@@ Енина Т. Н., Кузнецов В. А., Саламова Л. А. и др. Биомаркеры иммунного воспаления, фиброза, нейрогуморальной активации и катехоламинов у пациентов с устройствами для кардиоверсии-дефибрилляции и сердечной ресинхронизирующей терапии. Материалы Национального конгресса «Сердечная недостаточность 2018». Москва; 14-15 декабря 2018:23

8. Levey A. S., Stevens L. A., Schmid C. H. et al. A new equation to estimate glomerular filtration rate. Ann.Intern. Med. 2009; 150(9):604-12. doi: 10.7326 / 0003-4819-150-9-200905050-00006.

9. Smirnov A. V., Shilov E. M., Dobronravov V. A. National recommendations. Chronic kidney disease: basic principles of screening, diagnosis, prevention and approaches to treatment. St. Petersburg: Levsha, 2012:51 (In Russ.).@@ Смирнов А. В., Шилов Е. М., Добронравов В. А. Национальные рекомендации. Хроническая болезнь почек: основные принципы скрининга, диагностики, профилактики и подходы к лечению. СПб: Левша, 2012. С. 51.

10. Chernyavsky M. A., Irtyuga O. B., Yanishevsky S. N., Russian consensus on diagnostics and treatment of patients with carotid artery stenosis.Russian Journal of Cardiology. 2022;27(11):5284. (in Russ.) doi: 10.15829/1560-4071-2022-5284.@@ Чернявский М. А., Иртюга О. Б., Янишевский С. Н., и др. Российский консенсус по диагностике и лечению пациентов со стенозом сонных артерий. Российский кардиологический журнал. 2022;27(11):5284. doi: 10.15829/1560-4071-2022-5284.

11. Vukolova Y. Y., Gubareva I. V., Kiseleva G. I. et al. Association of proprotein convertase subtilisine/kexin type 9 (pcsk9) with vessel atherosclerosis of carotid and coronary basins in patients with arterial hypertension. A.Spirantskiy Vestnik Povolzhiya. 2019;19(5-6):54-59. (In Russ.)@@ Вуколова Ю. Ю., Губарева И. В., Киселева Г. И. и др. Связь пропротеина конвертазы субтилизин кексинового типа 9 с атеросклерозом сосудов каротидного и коронарного бассейнов у больных артериальной гипертонией // Аспирантский вестник Поволжья. - 2019. - Т. 19. - № 5-6. - C. 54-59.

12. Ware J. E., Snow K. K., Kosinski M. et el. SF-36 Health Survey. Manual and interpretation guide. The Health Institute, New England Medical Center. Boston, Mass.1993.

13. Ware J. E., Snow K. K., Kosinski M. et al. “SF-36 Health Survey: Guidance and Interpretation guide Manual Interpretation Guide, Lincoln, RI: Quality Metric Incorporation. 2003.

14. Nedoshivin A. O., Kutuzova A. E., Petrova N. N. et al. Study of the quality of life and the psychological status of patients with chronic heart failure. Heart failure. 2005;1:4. (In Russ.)@@ Недошивин А. О., Кутузова А. Е., Петрова Н. Н. и др. Изучение качества жизни и психологического статуса больных хронической сердечной недостаточностью. Сердечная недостаточность. 2005; 1:4.

15. Tok Yildiz F., Kaşikçi M. Impact of Training Based on Orem’s Theory on Self-Care Agency and Quality of Life in Patients with Coronary Artery Disease. J Nurs Res. 2020 Dec;28(6): e125. doi: 10.1097/JNR.0000000000000406.

16. Vukolova Y., Gubareva I., Galati G. et al. Proprotein convertase subtilisin kexin type 9 and main arteries atherosclerosis in patients with arterial hypertension. Minerva Cardiol Angiol. 2022 Apr 14. doi: 10.23736/S2724-5683.22.06008-2.

17. Lins L., Carvalho F. M. SF-36 total score as a single measure of health-related quality of life: Scoping review. SAGE Open Med. 2016 doi: 10.1177/2050312116671725.

18. Shabrov, A.V., Kukharchik G. A. Cardiological manifestations and complications of metabolic syndrome. University Therapeutic Journal. 2021;3(3):77-99. (in Russ.)@@ Шабров, А. В., Кухарчик Г. А. Кардиологические проявления и осложнения метаболического синдрома. University Therapeutic Journal. - 2021. - Т. 3, № 3. - С. 77-99.

19. Abdellatif A. M., Shuvalova Yu. A., Slivkina A. A., Kaminny A. I. The effect of metabolic syndrome on the long-term prognosis of patients with acute myocardial infarction with ST segment elevation. Atherosclerosis and Dyslipidemia. 2016;1 (22):68-75. (in Russ.)@@ Абдельлатиф А. М., Шувалова Ю. А., Сливкина А. А., Каминный А. И. Влияние метаболического синдрома на отдаленный прогноз пациентов с острым инфарктом миокарда с подъемом сегмента SТ. Атеросклероз и Дислипидемии. 2016. - Т. 1. -№ 22. - С. 68-75.